Related Experiment Video
Updated: Jul 4, 2026

12:31
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
Published on: February 28, 2015
Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging
David J Javier1, Nitin Nitin, Matthew Levy
1Department of Bioengineering, Rice University, Houston, Texas 77005, USA.
Bioconjugate Chemistry
|June 3, 2008
Summary
Researchers developed novel aptamer-gold nanoparticles for molecular imaging. This targeted contrast agent shows promise for detecting prostate-specific membrane antigen (PSMA) in cells.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Imaging
Background:
- Metallic nanoparticles offer potential for molecular-specific contrast agents.
- Aptamers are ideal candidates for molecular targeting applications due to their specificity.
Purpose of the Study:
- To develop aptamer-based gold nanoparticles as contrast agents for molecular imaging.
- To investigate a novel conjugation approach for creating targeted nanoparticles.
- To demonstrate the detection of prostate-specific membrane antigen (PSMA) using these agents.
Main Methods:
- Developed a novel conjugation strategy using extended aptamers and oligonucleotide-functionalized gold nanoparticles.
- Characterized the chemical and optical properties of aptamer-gold conjugates via size measurements and oligonucleotide quantitation.
- Utilized reflectance imaging to visualize PSMA-positive and PSMA-negative cell lines treated with anti-PSMA aptamer-gold conjugates.
Main Results:
- Successfully created aptamer-gold nanoparticle conjugates with characterized properties.
- Demonstrated the targeted detection of prostate-specific membrane antigen (PSMA) in cell lines.
- Obtained reflectance images differentiating PSMA(+) and PSMA(-) cells.
Conclusions:
- The novel aptamer-gold nanoparticle conjugation approach is effective for creating targeted molecular imaging agents.
- This strategy enables the specific detection of biomarkers like PSMA.
- The platform is adaptable for multifunctional agents and multimodal imaging applications.

